Detailed price information for Milestone Pharmaceuticals Inc (MIST-Q) from The Globe and Mail including charting and trades.

Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Express ...

Everest Medicines inks Asset Purchase Agreement with Corxel to develop and commercialize Cardamyst nasal spray in Greater China: Shanghai, China Tuesday, March 24, 2026, 16:00 Hrs ...

Everest Medicines today announced that it has entered into an Asset Purchase Agreement with Corxel Pharmaceuticals Hong Kong Limited ("CORXEL"). Under the agreement, the Company has acquired the ...

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative ...

MONTREAL and CHARLOTTE, N.C., March 16, 2026 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of ...

Detailed price information for Milestone Pharmaceuticals Inc (MIST-Q) from The Globe and Mail including charting and trades.

Conference Call and Webcast Scheduled for Friday, March 20 at 8:30am ETMONTREAL and CHARLOTTE, N.C., March 12, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced ...

John Lock was born with his heart on the opposite side of his chest. It was never an issue until he developed atrial fibrillation — a common heart condition that put his life at risk and created a ...

Tim Magilone, 62, came to the ER with AFib and was able to receive care in the new center with in days. Then had a surgery to correct his heart issue within three weeks He eats right, doesn’t smoke ...

Approximately 10.5 million Americans have atrial fibrillation (AFib), a condition that causes an irregular, often too fast, heartbeat. AFib increases the risk of stroke four to five times more than ...